Ladenburg Thalmann Downgrades Myriad Genetics (MYGN) to Sell

October 10, 2016 7:39 AM EDT
Get Alerts MYGN Hot Sheet
Price: $17.40 +2.41%

Rating Summary:
    7 Buy, 16 Hold, 6 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 21 | Down: 36 | New: 11
Trade MYGN Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Ladenburg Thalmann downgraded Myriad Genetics (NASDAQ: MYGN) from Neutral to Sell with a price target of $16.00.

For an analyst ratings summary and ratings history on Myriad Genetics click here. For more ratings news on Myriad Genetics click here.

Shares of Myriad Genetics closed at $21.35 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Downgrades, Hot Downgrades

Related Entities

Ladenburg Thalmann Financial Services

Add Your Comment